Home › Funds › Rhenman & Partners Asset Management AB › MDT

Rhenman & Partners Asset Management AB position in MDT

MEDTRONIC PLC · Health Care

Rhenman & Partners Asset Management AB reported holding 340,000 shares of MDT (MEDTRONIC PLC) in its Q3 2026 13F filing — a position valued at US$29.3M, representing 3.25% of its reported portfolio and ranking #4 among its reported holdings. Rhenman & Partners Asset Management AB has disclosed MDT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)340.00K sh
Reported value held$29.34M
Portfolio Weight3.25%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Rhenman & Partners Asset Management AB's MDT position evolved

Rhenman & Partners Asset Management AB first disclosed a stake in MDT in Q3 2023 at 375,000 shares (US$29.4M). The position peaked in Q4 2023 at 591,000 shares, worth US$48.7M. Across 13 filings, Rhenman & Partners Asset Management AB increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 340,000 shares valued at US$29.3M — an increase of 195,000 shares quarter over quarter.. Notable position changes include a 77% increase in Q3 2024 (shares fell 11% over the following quarter), a 70% trim in Q1 2026 (shares fell 9% over the following quarter), a 134% increase in Q3 2026 (shares rose 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 375.00K $29.39M New
Q4 2023 591.00K $48.69M Add
Q1 2024 325.00K $28.32M Reduce
Q2 2024 208.00K $16.37M Reduce
Q3 2024 368.00K $33.13M Add
Q4 2024 269.50K $21.53M Reduce
Q1 2025 255.00K $22.91M Reduce
Q2 2025 179.50K $15.65M Reduce
Q3 2025 205.00K $19.52M Add
Q4 2025 296.00K $28.43M Add
Q1 2026 90.00K $7.80M Reduce
Q2 2026 145.00K $11.34M Add
Q3 2026 340.00K $29.34M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MDT and 13F data

MDT (MEDTRONIC PLC) is a Health Care company. 20 other funds we track also report a position in MDT — the largest reported positions include MFS Investment Management (US$2.56B), Deutsche Bank AG (US$1.55B), First Eagle Investment Management (US$1.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MDT

All MDT fund holders →

FAQ

How long has Rhenman & Partners Asset Management AB held MDT?

Rhenman & Partners Asset Management AB has disclosed MDT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Rhenman & Partners Asset Management AB's current position in MDT?

As of Q3 2026, Rhenman & Partners Asset Management AB holds 340.00K shares of MDT (MEDTRONIC PLC), valued at $29.34M, representing 3.25% of its reported portfolio and ranking #4.

Has Rhenman & Partners Asset Management AB been buying or selling MDT?

In the latest 13F filing (Q3 2026), Rhenman & Partners Asset Management AB increased its position in MDT. The position peaked in Q4 2023 at 591.00K shares.

Which other funds hold MDT?

Other major institutional holders of MDT include MFS Investment Management, Deutsche Bank AG, First Eagle Investment Management, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.